Device Trial Radar · NCT03202472
Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery
Last checked: Nov 19, 2026Latest source record: Jul 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Aug 3, 2017
Primary completion
Jan 12, 2018
Study completion Feb 1, 2019
Sponsor
- Lead sponsor
- Jonsson Comprehensive Cancer CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- AstraZeneca
- First posted
- Jun 28, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This pilot clinical trial studies radiofrequency technology in locating non-palpable breast lesions in patients undergoing surgery. Placing a miniature radiofrequency tag or microchip in the breast lesion before surgery and using a handheld device to guide doctors during surgery may improve surgical outcomes in patients with non-palpable breast lesions.
Conditions
- Breast Neoplasm
- Lesion
Interventions
Implanted Medical DeviceDevice
Radiofrequency tag
MammographyProcedure
Undergo mammogram for image-guided placement of radiofrequency tag
Questionnaire AdministrationOther
Ancillary studies
Radiofrequency (RFID) -Guided LocalizationProcedure
Undergo radiofrequency-guided localization
UltrasonographyProcedure
Undergo ultrasound for image-guided placement of radiofrequency tag
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patients With Successful Placement of the Radiofrequency Tag Under Radiographic Guidance Confirmed by MammographyTime frame: at time of device placement, confirmed by mammography
- Patients With Successful Retrieval of the Radiofrequency Tag Confirmed by Specimen RadiographyTime frame: at time of surgery, within 30 days of tag implant
Locations
1 site in 1 country. Site status is shown where the registry gives one.
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.